Global Benign Prostatic Hyperplasia Testing Market Research Report 2023

Report ID: 1989398 | Published Date: Jan 2025 | No. of Page: 84 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Benign Prostatic Hyperplasia Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Urinalysis
        1.2.3 Prostate-Specific Antigen (PSA) Blood Test
        1.2.4 Urodynamic Test
        1.2.5 Cystoscopy
    1.3 Market by Application
        1.3.1 Global Benign Prostatic Hyperplasia Testing Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Diagnostic Centers
        1.3.4 Clinics
        1.3.5 Research Institutes
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Benign Prostatic Hyperplasia Testing Market Perspective (2017-2028)
    2.2 Benign Prostatic Hyperplasia Testing Growth Trends by Region
        2.2.1 Benign Prostatic Hyperplasia Testing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Benign Prostatic Hyperplasia Testing Historic Market Size by Region (2017-2022)
        2.2.3 Benign Prostatic Hyperplasia Testing Forecasted Market Size by Region (2023-2028)
    2.3 Benign Prostatic Hyperplasia Testing Market Dynamics
        2.3.1 Benign Prostatic Hyperplasia Testing Industry Trends
        2.3.2 Benign Prostatic Hyperplasia Testing Market Drivers
        2.3.3 Benign Prostatic Hyperplasia Testing Market Challenges
        2.3.4 Benign Prostatic Hyperplasia Testing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Benign Prostatic Hyperplasia Testing Players by Revenue
        3.1.1 Global Top Benign Prostatic Hyperplasia Testing Players by Revenue (2017-2022)
        3.1.2 Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Players (2017-2022)
    3.2 Global Benign Prostatic Hyperplasia Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Benign Prostatic Hyperplasia Testing Revenue
    3.4 Global Benign Prostatic Hyperplasia Testing Market Concentration Ratio
        3.4.1 Global Benign Prostatic Hyperplasia Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Benign Prostatic Hyperplasia Testing Revenue in 2021
    3.5 Benign Prostatic Hyperplasia Testing Key Players Head office and Area Served
    3.6 Key Players Benign Prostatic Hyperplasia Testing Product Solution and Service
    3.7 Date of Enter into Benign Prostatic Hyperplasia Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Benign Prostatic Hyperplasia Testing Breakdown Data by Type
    4.1 Global Benign Prostatic Hyperplasia Testing Historic Market Size by Type (2017-2022)
    4.2 Global Benign Prostatic Hyperplasia Testing Forecasted Market Size by Type (2023-2028)
5 Benign Prostatic Hyperplasia Testing Breakdown Data by Application
    5.1 Global Benign Prostatic Hyperplasia Testing Historic Market Size by Application (2017-2022)
    5.2 Global Benign Prostatic Hyperplasia Testing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Benign Prostatic Hyperplasia Testing Market Size (2017-2028)
    6.2 North America Benign Prostatic Hyperplasia Testing Market Size by Country (2017-2022)
    6.3 North America Benign Prostatic Hyperplasia Testing Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Benign Prostatic Hyperplasia Testing Market Size (2017-2028)
    7.2 Europe Benign Prostatic Hyperplasia Testing Market Size by Country (2017-2022)
    7.3 Europe Benign Prostatic Hyperplasia Testing Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size (2017-2028)
    8.2 Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Country (2017-2022)
    8.3 Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Benign Prostatic Hyperplasia Testing Market Size (2017-2028)
    9.2 Latin America Benign Prostatic Hyperplasia Testing Market Size by Country (2017-2022)
    9.3 Latin America Benign Prostatic Hyperplasia Testing Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size (2017-2028)
    10.2 Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Country (2017-2022)
    10.3 Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 AEternaZentaris
        11.1.1 AEternaZentaris Company Detail
        11.1.2 AEternaZentaris Business Overview
        11.1.3 AEternaZentaris Benign Prostatic Hyperplasia Testing Introduction
        11.1.4 AEternaZentaris Revenue in Benign Prostatic Hyperplasia Testing Business (2017-2022)
        11.1.5 AEternaZentaris Recent Development
    11.2 Astellas Pharma
        11.2.1 Astellas Pharma Company Detail
        11.2.2 Astellas Pharma Business Overview
        11.2.3 Astellas Pharma Benign Prostatic Hyperplasia Testing Introduction
        11.2.4 Astellas Pharma Revenue in Benign Prostatic Hyperplasia Testing Business (2017-2022)
        11.2.5 Astellas Pharma Recent Development
    11.3 Eli Lilly and Company
        11.3.1 Eli Lilly and Company Company Detail
        11.3.2 Eli Lilly and Company Business Overview
        11.3.3 Eli Lilly and Company Benign Prostatic Hyperplasia Testing Introduction
        11.3.4 Eli Lilly and Company Revenue in Benign Prostatic Hyperplasia Testing Business (2017-2022)
        11.3.5 Eli Lilly and Company Recent Development
    11.4 IntelGenx Technologies Corp
        11.4.1 IntelGenx Technologies Corp Company Detail
        11.4.2 IntelGenx Technologies Corp Business Overview
        11.4.3 IntelGenx Technologies Corp Benign Prostatic Hyperplasia Testing Introduction
        11.4.4 IntelGenx Technologies Corp Revenue in Benign Prostatic Hyperplasia Testing Business (2017-2022)
        11.4.5 IntelGenx Technologies Corp Recent Development
    11.5 Nymox Pharmaceutical Corporation
        11.5.1 Nymox Pharmaceutical Corporation Company Detail
        11.5.2 Nymox Pharmaceutical Corporation Business Overview
        11.5.3 Nymox Pharmaceutical Corporation Benign Prostatic Hyperplasia Testing Introduction
        11.5.4 Nymox Pharmaceutical Corporation Revenue in Benign Prostatic Hyperplasia Testing Business (2017-2022)
        11.5.5 Nymox Pharmaceutical Corporation Recent Development
    11.6 Protox Therapeutics
        11.6.1 Protox Therapeutics Company Detail
        11.6.2 Protox Therapeutics Business Overview
        11.6.3 Protox Therapeutics Benign Prostatic Hyperplasia Testing Introduction
        11.6.4 Protox Therapeutics Revenue in Benign Prostatic Hyperplasia Testing Business (2017-2022)
        11.6.5 Protox Therapeutics Recent Development
    11.7 Quest PharmaTech
        11.7.1 Quest PharmaTech Company Detail
        11.7.2 Quest PharmaTech Business Overview
        11.7.3 Quest PharmaTech Benign Prostatic Hyperplasia Testing Introduction
        11.7.4 Quest PharmaTech Revenue in Benign Prostatic Hyperplasia Testing Business (2017-2022)
        11.7.5 Quest PharmaTech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Benign Prostatic Hyperplasia Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Urinalysis
    Table 3. Key Players of Prostate-Specific Antigen (PSA) Blood Test
    Table 4. Key Players of Urodynamic Test
    Table 5. Key Players of Cystoscopy
    Table 6. Global Benign Prostatic Hyperplasia Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Benign Prostatic Hyperplasia Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Benign Prostatic Hyperplasia Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Benign Prostatic Hyperplasia Testing Market Share by Region (2017-2022)
    Table 10. Global Benign Prostatic Hyperplasia Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Benign Prostatic Hyperplasia Testing Market Share by Region (2023-2028)
    Table 12. Benign Prostatic Hyperplasia Testing Market Trends
    Table 13. Benign Prostatic Hyperplasia Testing Market Drivers
    Table 14. Benign Prostatic Hyperplasia Testing Market Challenges
    Table 15. Benign Prostatic Hyperplasia Testing Market Restraints
    Table 16. Global Benign Prostatic Hyperplasia Testing Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Benign Prostatic Hyperplasia Testing Market Share by Players (2017-2022)
    Table 18. Global Top Benign Prostatic Hyperplasia Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia Testing as of 2021)
    Table 19. Ranking of Global Top Benign Prostatic Hyperplasia Testing Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Benign Prostatic Hyperplasia Testing Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Benign Prostatic Hyperplasia Testing Product Solution and Service
    Table 23. Date of Enter into Benign Prostatic Hyperplasia Testing Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Benign Prostatic Hyperplasia Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Type (2017-2022)
    Table 27. Global Benign Prostatic Hyperplasia Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Type (2023-2028)
    Table 29. Global Benign Prostatic Hyperplasia Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Application (2017-2022)
    Table 31. Global Benign Prostatic Hyperplasia Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Application (2023-2028)
    Table 33. North America Benign Prostatic Hyperplasia Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Benign Prostatic Hyperplasia Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Benign Prostatic Hyperplasia Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Benign Prostatic Hyperplasia Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Benign Prostatic Hyperplasia Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Benign Prostatic Hyperplasia Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 43. AEternaZentaris Company Detail
    Table 44. AEternaZentaris Business Overview
    Table 45. AEternaZentaris Benign Prostatic Hyperplasia Testing Product
    Table 46. AEternaZentaris Revenue in Benign Prostatic Hyperplasia Testing Business (2017-2022) & (US$ Million)
    Table 47. AEternaZentaris Recent Development
    Table 48. Astellas Pharma Company Detail
    Table 49. Astellas Pharma Business Overview
    Table 50. Astellas Pharma Benign Prostatic Hyperplasia Testing Product
    Table 51. Astellas Pharma Revenue in Benign Prostatic Hyperplasia Testing Business (2017-2022) & (US$ Million)
    Table 52. Astellas Pharma Recent Development
    Table 53. Eli Lilly and Company Company Detail
    Table 54. Eli Lilly and Company Business Overview
    Table 55. Eli Lilly and Company Benign Prostatic Hyperplasia Testing Product
    Table 56. Eli Lilly and Company Revenue in Benign Prostatic Hyperplasia Testing Business (2017-2022) & (US$ Million)
    Table 57. Eli Lilly and Company Recent Development
    Table 58. IntelGenx Technologies Corp Company Detail
    Table 59. IntelGenx Technologies Corp Business Overview
    Table 60. IntelGenx Technologies Corp Benign Prostatic Hyperplasia Testing Product
    Table 61. IntelGenx Technologies Corp Revenue in Benign Prostatic Hyperplasia Testing Business (2017-2022) & (US$ Million)
    Table 62. IntelGenx Technologies Corp Recent Development
    Table 63. Nymox Pharmaceutical Corporation Company Detail
    Table 64. Nymox Pharmaceutical Corporation Business Overview
    Table 65. Nymox Pharmaceutical Corporation Benign Prostatic Hyperplasia Testing Product
    Table 66. Nymox Pharmaceutical Corporation Revenue in Benign Prostatic Hyperplasia Testing Business (2017-2022) & (US$ Million)
    Table 67. Nymox Pharmaceutical Corporation Recent Development
    Table 68. Protox Therapeutics Company Detail
    Table 69. Protox Therapeutics Business Overview
    Table 70. Protox Therapeutics Benign Prostatic Hyperplasia Testing Product
    Table 71. Protox Therapeutics Revenue in Benign Prostatic Hyperplasia Testing Business (2017-2022) & (US$ Million)
    Table 72. Protox Therapeutics Recent Development
    Table 73. Quest PharmaTech Company Detail
    Table 74. Quest PharmaTech Business Overview
    Table 75. Quest PharmaTech Benign Prostatic Hyperplasia Testing Product
    Table 76. Quest PharmaTech Revenue in Benign Prostatic Hyperplasia Testing Business (2017-2022) & (US$ Million)
    Table 77. Quest PharmaTech Recent Development
    Table 78. Research Programs/Design for This Report
    Table 79. Key Data Information from Secondary Sources
    Table 80. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Benign Prostatic Hyperplasia Testing Market Share by Type: 2021 VS 2028
    Figure 2. Urinalysis Features
    Figure 3. Prostate-Specific Antigen (PSA) Blood Test Features
    Figure 4. Urodynamic Test Features
    Figure 5. Cystoscopy Features
    Figure 6. Global Benign Prostatic Hyperplasia Testing Market Share by Application in 2021 & 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Diagnostic Centers Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. Research Institutes Case Studies
    Figure 11. Benign Prostatic Hyperplasia Testing Report Years Considered
    Figure 12. Global Benign Prostatic Hyperplasia Testing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Benign Prostatic Hyperplasia Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Benign Prostatic Hyperplasia Testing Market Share by Region: 2021 VS 2028
    Figure 15. Global Benign Prostatic Hyperplasia Testing Market Share by Players in 2021
    Figure 16. Global Top Benign Prostatic Hyperplasia Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia Testing as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Benign Prostatic Hyperplasia Testing Revenue in 2021
    Figure 18. North America Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Benign Prostatic Hyperplasia Testing Market Share by Country (2017-2028)
    Figure 20. United States Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Benign Prostatic Hyperplasia Testing Market Share by Country (2017-2028)
    Figure 24. Germany Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Share by Region (2017-2028)
    Figure 32. China Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Benign Prostatic Hyperplasia Testing Market Share by Country (2017-2028)
    Figure 40. Mexico Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Share by Country (2017-2028)
    Figure 44. Turkey Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. AEternaZentaris Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2017-2022)
    Figure 47. Astellas Pharma Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2017-2022)
    Figure 48. Eli Lilly and Company Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2017-2022)
    Figure 49. IntelGenx Technologies Corp Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2017-2022)
    Figure 50. Nymox Pharmaceutical Corporation Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2017-2022)
    Figure 51. Protox Therapeutics Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2017-2022)
    Figure 52. Quest PharmaTech Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2017-2022)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AEternaZentaris
Astellas Pharma
Eli Lilly and Company
IntelGenx Technologies Corp
Nymox Pharmaceutical Corporation
Protox Therapeutics
Quest PharmaTech
Frequently Asked Questions
Benign Prostatic Hyperplasia Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Benign Prostatic Hyperplasia Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Benign Prostatic Hyperplasia Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Benzyl Bromide

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Berries

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Beryllium Alloys

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Betaine Anhydrous

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More